This grant offered by the National Center for Advancing Translational Sciences (NCATS) aims to support the development of 3D-bioprinted skin tissue models for drug discovery, efficacy studies, and toxicology research. The program encourages collaboration between NCATS intramural scientists and external researchers to leverage expertise in bioprinting, assay development, and drug screening. Extramural investigators will contribute cell resources, disease knowledge, and model validation, while NCATS provides support for bioprinting, material characterization, and screening with molecular libraries. The goal is to advance drug discovery through innovative bioprinting technologies and collaborative research efforts. Application deadline: Apr 14, 2017.
Opportunity ID: 291780
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | RFA-TR-17-007 |
| Funding Opportunity Title: | NCATS Pilot Program for Collaborative Drug Discovery Research using Bioprinted Skin Tissue (U18) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Cooperative Agreement |
| Category of Funding Activity: | Health |
| Category Explanation: | – |
| Expected Number of Awards: | – |
| Assistance Listings: | 93.350 — National Center for Advancing Translational Sciences |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Feb 13, 2017 |
| Last Updated Date: | – |
| Original Closing Date for Applications: | Apr 14, 2017 |
| Current Closing Date for Applications: | Apr 14, 2017 |
| Archive Date: | May 15, 2017 |
| Estimated Total Program Funding: | $3,000,000 |
| Award Ceiling: | $400,000 |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | State governments Public and State controlled institutions of higher education Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education City or township governments Private institutions of higher education Small businesses Native American tribal governments (Federally recognized) County governments Independent school districts Others (see text field entitled “Additional Information on Eligibility” for clarification) For profit organizations other than small businesses Native American tribal organizations (other than Federally recognized tribal governments) Special district governments Public housing authorities/Indian housing authorities |
| Additional Information on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are not allowed. |
Additional Information
| Agency Name: | National Institutes of Health |
| Description: | The goal of this Funding Opportunity Announcement (FOA) is to enable the development of 3D-bioprinted tissue models for drug discovery, including efficacy studies and toxicology research through a collaborative arrangement between the 3-D Bioprinting Program at the National Center for Advancing Translational Sciences (NCATS) and extramural scientists. NCATS intramural scientists will provide expertise for 3-D bioprinting, assay development and drug screening stages of the projects. Extramural investigators will provide appropriate cell resources, disease expertise and model validation in collaboration with NCATS to perform drug screening of bioprinted materials. The research application will involve 3-D bioprinting in a screening format of patient-derived cells supplied by the extramural investigators, characterization and validation of bioprinted materials by NCATS investigators and extramural collaborators, and screening of appropriate molecular libraries. |
| Link to Additional Information: | http://grants.nih.gov/grants/guide/rfa-files/RFA-TR-17-007.html |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV Email:FBOWebmaster@OD.NIH.GOV |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
Related Documents
There are no related documents on this grant.
Packages
| Agency Contact Information: | NIH OER Webmaster FBOWebmaster@OD.NIH.GOV Email: FBOWebmaster@OD.NIH.GOV |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| FORMS-D | Use for due dates on or after May 25, 2016 | PKG00230831 | Feb 14, 2017 | Apr 14, 2017 | View |
Package 1
Mandatory forms
291780 RR_SF424_2_0-2.0.pdf
291780 PHS398_CoverPageSupplement_3_0-3.0.pdf
291780 RR_OtherProjectInfo_1_3-1.3.pdf
291780 PerformanceSite_2_0-2.0.pdf
291780 RR_KeyPersonExpanded_2_0-2.0.pdf
291780 RR_Budget_1_3-1.3.pdf
291780 PHS398_ResearchPlan_3_0-3.0.pdf
Optional forms
291780 RR_SubawardBudget30_1_3-1.3.pdf
291780 PHS_Inclusion_Enrollment_Report-1.0.pdf
291780 PHS_AssignmentRequestForm-1.0.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
